Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

John Harris has just been awarded an honorary MA in recognition of 50 years of service to the Department of Pharmacology and reflects on highlights over the past five decades

John Harris (left) receives his honorary MA at the Sheldonian Theatre. © Ian Wallman

He may have just received an honorary MA in recognition of 50 years’ service to the Department of Pharmacology, but John Harris still recalls his first day nerves aged 19.

“I think it was actually my mum who saw the job advertised,” said Oxford-born John, who started out as a Junior Technician in the Department of Pharmacology Workshop in 1969.

“I remember I came in early on my first day and I was a little bit nervous.

“I was mainly building things for the researchers in the labs and making sure everything was working in the classrooms for the medical students.”

John has remained in the workshop ever since and past his 50-year milestone in October 2019, when the department held a reception for him. Then, on 29 February 2020, he received his honorary MA at the Sheldonian Theatre.

“Everyone made me feel so special on the day,” said John, who particularly enjoyed part of the ceremony outside afterwards where, as a member of the procession, he had to doff his cap to applauding students who had received their degrees.

Read the full story on the University of Oxford website

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.